Malignant Nasopharyngeal Neoplasm — Trials

Malignant Nasopharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

771 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 261
Recruiting: 139
Ph III recruiting: 56
Growth YoY: +5.2%
Industry share: 9%
Top sponsor: Sun Yat-sen University
Termination share: 24.1%
Trials / 1,000 deaths: 376.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 51–80 of 80 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01534585	Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma	completed	Phase 1 / Phase 2	48	Taizhou HospitalOTHER	1	Apr 17, 2018	clinicaltrials
NCT02776124	Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma Patients	completed	Phase 2	60	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER	1	Mar 19, 2018